This grant funds collaborative scientific risk assessments and harmonisation of methodologies for vector-borne diseases in Northern Europe to support evidence-based public health decisions.
European Commission has archived this opportunity.
Funder: European Commission
Due Dates: February 4, 2026: Full proposal submission deadline (Lot 1, 17:00 CET/Brussels)
Funding Amounts: Up to €1,500,000 per Lot over 4 years; total call budget €6,000,000; individual Specific Agreements typically €250,000–€500,000.
Summary: Supports partnerships to advance and harmonise scientific risk assessments for vector-borne diseases in Northern Europe.
Key Information: Open only to organisations on EFSA's Article 36 list of competent organisations.
This grant opportunity aims to strengthen the capacity for risk assessment of vector-borne diseases (VBDs) at the European Union level, with a specific focus on Northern Europe (Lot 1: Lithuania, Denmark, Latvia, Ireland, Finland, Estonia, Sweden, Norway, Iceland). By fostering long-term collaborations among European institutions and harmonising risk assessment methodologies, the program seeks to optimize scientific knowledge generation and support evidence-based decision-making. The initiative is structured around multi-year framework partnership agreements, enabling joint programming, coordinated risk assessments, and efficient resource use across participating countries.